Natural therapeutics: Difference between revisions

→‎The endocannabinoid system: + 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome', a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.
m (mv content unchanged)
(→‎The endocannabinoid system: + 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome', a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.)
Line 41: Line 41:
* [https://www.intechopen.com/books/cannabinoids-in-health-and-disease/dietary-omega-6-omega-3-and-endocannabinoids-implications-for-brain-health-and-diseases 'Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases'], a 2016 peer-reviewed chapter.
* [https://www.intechopen.com/books/cannabinoids-in-health-and-disease/dietary-omega-6-omega-3-and-endocannabinoids-implications-for-brain-health-and-diseases 'Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases'], a 2016 peer-reviewed chapter.
* [https://www.researchgate.net/publication/42369817_Endocannabinoids_and_pregnancy 'Endocannabinoids and pregnancy'], a 2010 literature review
* [https://www.researchgate.net/publication/42369817_Endocannabinoids_and_pregnancy 'Endocannabinoids and pregnancy'], a 2010 literature review
* [https://www.sciencedaily.com/releases/2019/02/190206115550.htm 'Endocannabinoid system, a target to improve cognitive disorders in models of Down syndrome'], a 2019 animal model study found downregulating CB1 receptors beneficial for the mice.


=== The endocannabinoid receptors ===  
=== The endocannabinoid receptors ===